Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Sonoma Pharmaceuticals, Inc.

Sonoma Pharmaceuticals, Inc. (SNOA) Stock Overview

Explore Sonoma Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

SNOA●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$1.33
$0.04(2.61%)
U.S. Market is Open · 13:57

Sonoma Pharmaceuticals, Inc. (SNOA)

Meyka AI Score

Z

Key Financials

Market Cap2.3M
P/E Ratio-1.12
EPS (TTM)$-1.18
ROE-0.54%
Fundamental Analysis

AI Price Forecasts

1 Month$1.66
3 Months$0.00
1 Year Target$0.31

SNOA Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Sonoma Pharmaceuticals, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of SNOA on the NASDAQ shows an RSI of 60.33, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.31 for the NASDAQ listing.

Key metrics behind Sonoma Pharmaceuticals, Inc.'s NASDAQ-traded stock include a P/E ratio of -1.12 and a market capitalization of 2.3M. Combined with our AI analysis, these give both institutional and retail investors a clear view of SNOA on the NASDAQ.

Price Performance (NASDAQ: SNOA)

1-Day Change
N/A
5-Day Change
7.03%
1-Month Change
8.73%
3-Month Change
16.10%
6-Month Change
-50.18%
Year-to-Date (YTD) Change
-62.36%
1-Year Change
-54.33%
3-Year Change
-92.59%
5-Year Change
-98.81%
All-Time (Max) Change
-100.00%

Contact Information

https://www.sonomapharma.com
800 759 9305
5445 Conestoga Court, Boulder, CO, 80301

Company Facts

100 Employees
IPO DateJan 25, 2007
CountryUS
Actively Trading

Frequently Asked Questions